Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 1
2006 1
2007 2
2008 5
2009 2
2011 3
2014 3
2015 2
2016 6
2017 7
2018 7
2019 11
2020 11
2021 11
2022 9
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial.
Broers AEC, de Jong CN, Bakunina K, Hazenberg MD, van Marwijk Kooy M, de Groot MR, van Gelder M, Kuball J, van der Holt B, Meijer E, Cornelissen JJ. Broers AEC, et al. Among authors: meijer e. Blood Adv. 2022 Jun 14;6(11):3378-3385. doi: 10.1182/bloodadvances.2021005847. Blood Adv. 2022. PMID: 35143644 Free PMC article. Clinical Trial.
Perspectives for Buck Kids in Dairy Goat Farming.
Meijer E, Goerlich VC, van den Brom R, Giersberg MF, Arndt SS, Rodenburg TB. Meijer E, et al. Front Vet Sci. 2021 Oct 15;8:662102. doi: 10.3389/fvets.2021.662102. eCollection 2021. Front Vet Sci. 2021. PMID: 34722689 Free PMC article. Review.
Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
van Lier YF, Rolling T, Armijo GK, Zhai B, Haverkate NJE, Meijer E, Nur E, Blom B, Peled JU, van den Brink MRM, Hohl TM, Hazenberg MD, Markey KA. van Lier YF, et al. Among authors: meijer e. Transplant Cell Ther. 2023 Jan;29(1):63.e1-63.e5. doi: 10.1016/j.jtct.2022.10.011. Epub 2022 Oct 21. Transplant Cell Ther. 2023. PMID: 36280104 Free PMC article. Clinical Trial.
Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning.
Sijs-Szabo A, Dinmohamed AG, Versluis J, van der Holt B, Bellido M, Hazenberg MD, van Gelder M, Schaap NPM, Meijer E, van der Wagen LE, Halkes CJM, Rijneveld AW, Cornelissen JJ. Sijs-Szabo A, et al. Among authors: meijer e. Transplantation. 2023 Dec 1;107(12):2561-2567. doi: 10.1097/TP.0000000000004706. Epub 2023 Jun 30. Transplantation. 2023. PMID: 37389645
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Beksac M, Iacobelli S, Koster L, Cornelissen J, Griskevicius L, Rabin NK, Stoppa AM, Meijer E, Mear JB, Zeerleder S, Mayer J, Fenk R, Fegueux N, Chevallier P, Konirova E, Snowden JA, Engelhardt M, Orchard K, Hulin C, Schaap N, Sossa C, Elmaagacli A, McLornan DP, Hayden PJ, Schönland S, Yakoub-Agha I. Beksac M, et al. Among authors: meijer e. Bone Marrow Transplant. 2023 Aug;58(8):916-923. doi: 10.1038/s41409-023-01999-1. Epub 2023 May 9. Bone Marrow Transplant. 2023. PMID: 37160942
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT.
Chen J, Labopin M, Pabst T, Zhang X, Jiang E, Tucci A, Cornelissen J, Meijer E, Khevelidze I, Polge E, Wu D, Mohty M, Gorin NC. Chen J, et al. Among authors: meijer e. Bone Marrow Transplant. 2023 Dec;58(12):1322-1330. doi: 10.1038/s41409-023-02070-9. Epub 2023 Aug 28. Bone Marrow Transplant. 2023. PMID: 37640797 Free PMC article.
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Nagler A, Labopin M, Dholaria B, Blaise D, Bondarenko S, Vydra J, Choi G, Rovira M, Reményi P, Meijer E, Bulabois CE, Diez-Martin JL, Yakoub-Agha I, Brissot E, Spyridonidis A, Sanz J, Patel A, Arat M, Bazarbachi A, Bug G, Savani BN, Giebel S, Ciceri F, Mohty M. Nagler A, et al. Among authors: meijer e. Br J Haematol. 2023 Jun;201(6):1169-1178. doi: 10.1111/bjh.18765. Epub 2023 Mar 22. Br J Haematol. 2023. PMID: 36949658
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT.
Sanz J, Labopin M, Pabst T, Versluis J, Van Gorkom G, Meijer E, Gedde-Dahl T, Montoro J, Arcese W, Pérez-Simón JA, Schaap N, Maertens J, Vrhovac R, Lanza F, Gorin NC, Mohty M, Ciceri F. Sanz J, et al. Among authors: meijer e. Bone Marrow Transplant. 2023 Nov;58(11):1197-1202. doi: 10.1038/s41409-023-02075-4. Epub 2023 Aug 8. Bone Marrow Transplant. 2023. PMID: 37553468
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis.
Hermans SJF, Versluis J, Labopin M, Giebel S, van Norden Y, Moiseev I, Blaise D, Díez Martín JL, Meijer E, Rovira M, Choi G, Raiola AM, Koc Y, Reményi P, Vydra J, Kröger N, Sica S, Martino M, van Gorkom G, Chevallier P, Busca A, Herrera Arroyo C, Brissot E, Peric Z, Nagler A, Shouval R, Ciceri F, Cornelissen JJ, Mohty M. Hermans SJF, et al. Among authors: meijer e. Hemasphere. 2023 Feb 21;7(3):e846. doi: 10.1097/HS9.0000000000000846. eCollection 2023 Mar. Hemasphere. 2023. PMID: 36844179 Free PMC article.
82 results